Stay updated on Pediatric Fosaprepitant Combo for Nausea Clinical Trial
Sign up to get notified when there's something new on the Pediatric Fosaprepitant Combo for Nausea Clinical Trial page.

Latest updates to the Pediatric Fosaprepitant Combo for Nausea Clinical Trial page
- Check5 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.7%
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check27 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check56 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check70 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study information regarding the efficacy and safety of fosaprepitant and ondansetron for preventing chemotherapy-induced nausea and vomiting in pediatric patients, while adding new identifiers and a revision number related to the study.SummaryDifference24%
- Check78 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
Stay in the know with updates to Pediatric Fosaprepitant Combo for Nausea Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Fosaprepitant Combo for Nausea Clinical Trial page.